These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2850211)

  • 1. Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channels.
    Kohlhardt M; Fichtner H
    Eur J Pharmacol; 1988 Oct; 156(1):55-62. PubMed ID: 2850211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of drug-induced blockade of Na+ currents: interaction of antiarrhythmic compounds with DPI-modified single cardiac Na+ channels.
    Kohlhardt M; Fichtner H; Fröbe U; Herzig JW
    Circ Res; 1989 May; 64(5):867-81. PubMed ID: 2539922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically modified cardiac Na+ channels and their sensitivity to antiarrhythmics: is there a hidden drug receptor?
    Benz I; Kohlhardt M
    J Membr Biol; 1994 May; 139(3):191-201. PubMed ID: 7745598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells.
    Kodama I; Suzuki R; Honjo H; Toyama J
    Br J Pharmacol; 1992 Nov; 107(3):813-20. PubMed ID: 1335340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K; Lindner W; Schnedl H; Kukovetz WR
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
    Kohlhardt M; Fichtner H
    J Membr Biol; 1988 May; 102(2):105-19. PubMed ID: 2458471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of Vmax block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle.
    Kohlhardt M; Seifert C
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):235-44. PubMed ID: 2414674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of cardiac Na+ channels to antiarrhythmic drugs: the role of inactivation.
    Benz I; Kohlhardt M
    J Membr Biol; 1991 Jun; 122(3):267-78. PubMed ID: 1656048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological properties of the propafenone-analogue GE 68 (1-[3-(phenylethyl)-2-benzofuryl]-2-(propylamino)-ethanol) in isolated preparations and ventricular myocytes of guinea-pig hearts.
    Lemmens-Gruber R; Marei H; Heistracher P
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):230-8. PubMed ID: 9050017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles.
    Valenzuela C; Delpón E; Tamargo J
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):423-31. PubMed ID: 2465442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
    Valenzuela C; Snyders DJ; Bennett PB; Tamargo J; Hondeghem LM
    Circulation; 1995 Nov; 92(10):3014-24. PubMed ID: 7586272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.
    Pérez O; Gay P; Franqueza L; Carrón R; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block of sodium currents by antiarrhythmic agents: analysis of the electrophysiologic effects of propafenone in heart muscle.
    Kohlhardt M
    Am J Cardiol; 1984 Nov; 54(9):13D-19D. PubMed ID: 6093494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insensitivity of the open state of (-)-DPI-modified cardiac Na+ channels to the blocking effects of the (+) enantiomer.
    Kohlhardt M
    Eur J Pharmacol; 1989 Sep; 168(1):115-8. PubMed ID: 2555199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselectivity of asocainol studied at different conditions: a novel approach to check the feasibility of molecular models of antiarrhythmic drug action.
    Gödicke J; Herzig S; Mescheder A; Mohr K; Steinke F
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):345-51. PubMed ID: 1328897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
    Greenberg S; Cantor E; Paul J
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of inactivation and blockade of cardiac Na+ channels by DPI 201-106: different voltage-dependencies of the drug actions.
    Kohlhardt M; Fröbe U; Herzig JW
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):183-8. PubMed ID: 2436060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles.
    Pérez O; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1994 Mar; 111(3):717-22. PubMed ID: 8019750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing effects of salicylate on tonic and phasic block of Na+ channels by class 1 antiarrhythmic agents in the ventricular myocytes and the guinea pig papillary muscle.
    Tanaka Y; Hisatome I; Miyamoto J; Urashima T; Ikeda K; Yamanouchi Y; Sasaki N; Kinugawa T; Ogino K; Igawa O; Yoshida A; Shigemasa C; Kurata Y; Sato R
    Biochim Biophys Acta; 1999 May; 1418(2):320-34. PubMed ID: 10320683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective interactions of (R)- and (S)-propafenone with the cardiac sodium channel.
    Schreibmayer W; Lindner W
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):324-31. PubMed ID: 1381026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.